Connectome-Based Prediction of Cocaine Abstinence

Am J Psychiatry. 2019 Feb 1;176(2):156-164. doi: 10.1176/appi.ajp.2018.17101147. Epub 2019 Jan 4.

Abstract

Objective: The authors sought to identify a brain-based predictor of cocaine abstinence by using connectome-based predictive modeling (CPM), a recently developed machine learning approach. CPM is a predictive tool and a method of identifying networks that underlie specific behaviors ("neural fingerprints").

Methods: Fifty-three individuals participated in neuroimaging protocols at the start of treatment for cocaine use disorder, and again at the end of 12 weeks of treatment. CPM with leave-one-out cross-validation was conducted to identify pretreatment networks that predicted abstinence (percent cocaine-negative urine samples during treatment). Networks were applied to posttreatment functional MRI data to assess changes over time and ability to predict abstinence during follow-up. The predictive ability of identified networks was then tested in a separate, heterogeneous sample of individuals who underwent scanning before treatment for cocaine use disorder (N=45).

Results: CPM predicted abstinence during treatment, as indicated by a significant correspondence between predicted and actual abstinence values (r=0.42, df=52). Identified networks included connections within and between canonical networks implicated in cognitive/executive control (frontoparietal, medial frontal) and in reward responsiveness (subcortical, salience, motor/sensory). Connectivity strength did not change with treatment, and strength at posttreatment assessment also significantly predicted abstinence during follow-up (r=0.34, df=39). Network strength in the independent sample predicted treatment response with 64% accuracy by itself and 71% accuracy when combined with baseline cocaine use.

Conclusions: These data demonstrate that individual differences in large-scale neural networks contribute to variability in treatment outcomes for cocaine use disorder, and they identify specific abstinence networks that may be targeted in novel interventions.

Keywords: Cocaine; Cognitive Neuroscience; Psychoactive Substance Use Disorder.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Behavior Therapy
  • Brain / diagnostic imaging*
  • Cholinesterase Inhibitors / therapeutic use
  • Cocaine-Related Disorders / complications
  • Cocaine-Related Disorders / diagnostic imaging*
  • Cocaine-Related Disorders / rehabilitation
  • Cognition
  • Connectome*
  • Executive Function
  • Female
  • Functional Neuroimaging
  • Galantamine / therapeutic use
  • Humans
  • Individuality
  • Machine Learning
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neural Pathways / diagnostic imaging
  • Opiate Substitution Treatment
  • Opioid-Related Disorders / complications
  • Opioid-Related Disorders / drug therapy
  • Prognosis
  • Reward
  • Treatment Outcome

Substances

  • Cholinesterase Inhibitors
  • Galantamine